Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Suzanne G. Courter
Observed names:
S Courter,
S G Courter,
S. G. COURTER,
S.G Courter,
Suzanne Courter,
Suzanne G Courter
show all 6
Institutions:
Beth Israel Deaconess Medical Center,
Harvard University,
Royal Free London NHS Foundation Trust,
Georgetown University,
Georgetown University Medical Center,
The Royal Free Hospital
show all 6
Observed institutions:
Beth Israel Deaconess Medical Center,
Children's National,
Children's Hospital Los Angeles,
Harvard University,
Royal Free London NHS Foundation Trust,
Georgetown University,
Georgetown University Medical Center,
The Royal Free Hospital,
Baxter (United States)
show all 9
OpenAlex ID:
A5108423334
A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.
1994
·
G L Bray
, E D Gomperts
, et al.
·
Blood
·
394
Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates
2001
·
David A. Roth
, Craig M. Kessler
, et al.
·
Blood
·
189
A Multicenter Study of Recombinant Factor VIII (RecombinateTM) in Previously Treated Patients with Hemophilia A
1997
·
G C White
, S Courter
, et al.
·
Thrombosis and Haemostasis
·
141
Clinical evaluation of recombinant factor IX.
1998
·
G White
, A Shapiro
, et al.
·
PubMed
·
111
Clinical evaluation of B-domain deleted recombinant factor VIII in previously treated patients
2001
·
S.G Courter
, C.L Bedrosian
·
Seminars in Hematology
·
108
Long-term use of IgA-depleted intravenous immunoglobulin in immunodeficient subjects with anti-IgA antibodies
1993
·
Charlotte Cunningham-Rundles
, Zhuo Zhou
, et al.
·
Journal of Clinical Immunology
·
97
Treatment of Hemophilia A with a Highly Purified Factor VIII Concentrate Prepared by Anti-FVIIIc Immunoaffinity Chromatography
1992
·
Joseph E Addiego
, Edward Gomperts
, et al.
·
Thrombosis and Haemostasis
·
79
Clinical evaluation of B-domain deleted recombinant factor VIII in previously untreated patients
2001
·
S.G Courter
, C.L Bedrosian
·
Seminars in Hematology
·
77
Use of recombinant factor IX in subjects with haemophilia B undergoing surgery
2002
·
M. V. RAGNI
, K. J. PASI
, et al.
·
Haemophilia
·
65
Hepatic artery ligation and portal vein infusion for liver metastases from colon cancer.
1984
·
L R Laufman
, T A Nims
, et al.
·
Journal of Clinical Oncology
·
25
Epitope specificity and functional characterization of factor VIII inhibitors
1995
·
Recombinate and Kogenate Study groups
, Dorothea Scandella
, et al.
·
Advances in experimental medicine and biology
·
22
Safety of an intravenous immunoglobulin preparation: lack of seroconversion for human immunodeficiency virus antibodies.
1987
·
M L Lee
, H S Kingdon
, et al.
·
PubMed
·
6
A multicenter study of recombinant factor VIII (RecombinateTM) in previously treated patients with hemophilia A.
1997
·
GC White
, S Courter
, et al.
·
Haemophilia
·
4
Clinical Trials of Recombinant Factor VIII
1991
·
Gilbert C. White
, Campbell W. McMillan
, et al.
·
Springer eBooks
·
2
Quality of Life Assessment versus Clinical Outcome Measures: An Example
1994
·
Martin L. Lee
, Suzanne G. Courter
·
Drug Information Journal
·
1
A clinical evaluation of genetic stability.
1994
·
E D Gomperts
, S G Courter
, et al.
·
PubMed
·
1
Recovery and Survival Studies of a New Factor Viii Product
1987
·
J E Addiego
, P Bailey
, et al.
·
Thrombosis and Haemostasis
Intraperitoneal chemotherapy: introduction into a community hospital.
1986
·
M P Dunn
, K A Krzeczowski
, et al.
·
PubMed
Show more works
View as search
Works count:
18
Citation count:
1,322
H-index:
11
I10-index:
11
Year
Topic
Type